California 2021-2022 Regular Session

California Assembly Bill AB1344 Compare Versions

OldNewDifferences
1-Assembly Bill No. 1344 CHAPTER 480 An act to amend Section 121349 of the Health and Safety Code, relating to public health. [ Approved by Governor October 04, 2021. Filed with Secretary of State October 04, 2021. ] LEGISLATIVE COUNSEL'S DIGESTAB 1344, Arambula. State Department of Public Health: needle and syringe exchange services.Existing law authorizes the State Department of Public Health to authorize certain entities to apply to the department to provide hypodermic needle and syringe exchange services in any location where the department determines that the conditions exist for the rapid spread of human immunodeficiency virus (HIV), viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes, and requires the department to provide for a period of public comment during that application process, as specified. Existing law prescribes the standards that apply to an entity that has been authorized to provide these services.Existing law, the California Environmental Quality Act, requires a lead agency, as defined, to prepare, or cause to be prepared, and certify the completion of, an environmental impact report on a project that it proposes to carry out or approve that may have a significant effect on the environment, or to adopt a negative declaration if it finds that the project will not have that effect.This bill would expressly exempt the above-described needle and syringe exchange services application submissions, authorizations, and operations from review under the California Environmental Quality Act. The bill would declare that this provision is intended to be declaratory of existing law. The bill would state that the provisions relating to needle exchange programs are severable.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 121349 of the Health and Safety Code is amended to read:121349. (a) The Legislature finds and declares that scientific data from needle exchange programs in the United States and in Europe have shown that the exchange of used hypodermic needles and syringes for clean hypodermic needles and syringes does not increase drug use in the population, can serve as an important bridge to treatment and recovery from drug abuse, and can curtail the spread of human immunodeficiency virus (HIV) infection among the intravenous drug user population.(b) In order to reduce the spread of HIV infection and bloodborne hepatitis among the intravenous drug user population within California, the Legislature hereby authorizes a clean needle and syringe exchange project pursuant to this chapter in any city, county, or city and county upon the action of a county board of supervisors and the local health officer or health commission of that county, or upon the action of the city council, the mayor, and the local health officer of a city with a health department, or upon the action of the city council and the mayor of a city without a health department.(c) In order to reduce the spread of HIV infection, viral hepatitis, and other potentially deadly bloodborne infections, the State Department of Public Health may, notwithstanding any other law, authorize entities that provide services set forth in paragraph (1) of subdivision (d), and that have sufficient staff and capacity to provide the services described in Section 121349.1, as determined by the department, to apply for authorization under this chapter to provide hypodermic needle and syringe exchange services consistent with state standards in any location where the department determines that the conditions exist for the rapid spread of HIV, viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes. Authorization shall be made after consultation with the local health officer and local law enforcement leadership, and after a period of public comment, as described in subdivision (e). In making the determination, the department shall balance the concerns of law enforcement with the public health benefits. The authorization shall not be for more than two years. Before the end of the two-year period, the department may reauthorize the program in consultation with the local health officer and local law enforcement leadership.(d) In order for an entity to be authorized to conduct a project pursuant to this chapter, its application to the department shall demonstrate that the entity complies with all of the following minimum standards:(1) The entity provides, directly or through referral, all of the following services:(A) Drug abuse treatment services.(B) HIV or hepatitis screening.(C) Hepatitis A and hepatitis B vaccination.(D) Screening for sexually transmitted infections.(E) Housing services for the homeless, for victims of domestic violence, or other similar housing services.(F) Services related to provision of education and materials for the reduction of sexual risk behaviors, including, but not limited to, the distribution of condoms.(2) The entity has the capacity to commence needle and syringe exchange services within three months of authorization.(3) The entity has adequate funding to do all of the following at reasonably projected program participation levels:(A) Provide needles and syringe exchange services for all of its participants.(B) Provide HIV and viral hepatitis prevention education services for all of its participants.(C) Provide for the safe recovery and disposal of used syringes and sharps waste from all of its participants.(4) The entity has the capacity, and an established plan, to collect evaluative data in order to assess program impact, including, but not limited to, all of the following:(A) The total number of persons served.(B) The total number of needles and syringes distributed, recovered, and disposed of.(C) The total numbers and types of referrals to drug treatment and other services.(e) If the application is provisionally deemed appropriate by the department, the department shall, at least 45 days prior to approval of the application, provide for a period of public comment as follows:(1) Post on the departments internet website the name of the applicant, the nature of the services, and the location where the applying entity will provide the services.(2) Send a written and an email notice to the local health officer of the affected jurisdiction.(3) Send a written and an email notice to the chief of police, the sheriff, or both, as appropriate, of the jurisdictions in which the program will operate.(f) The department shall establish and maintain on its internet website the address and contact information of programs providing hypodermic needle and syringe exchange services pursuant to this chapter.(g) The authorization provided under this section is only for a clean needle and syringe exchange project as described in Section 121349.1.(h) (1) Needle and syringe exchange services application submissions, authorizations, and operations performed pursuant to this chapter shall be exempt from review under the California Environmental Quality Act, Division 13 (commencing with Section 21000) of the Public Resources Code.(2) This subdivision is intended to be declaratory of existing law.(i) If the department, in its discretion, determines that a state authorized syringe exchange program continues to meet all standards set forth in subdivision (d) and that a public health need exists, it may administratively approve amendments to a programs operations including, but not limited to, modifications to the time, location, and type of services provided, including the designation as a fixed site or a mobile site. The amendment approval is not subject to the noticing requirements of subdivision (e).(j) The department shall have 30 business days to review and respond to the applicants request for amendment of the authorization. If the department does not respond in writing within 30 business days, the request shall be deemed denied.(k) The provisions of this section are severable. If any provision of this section or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
1+Enrolled September 03, 2021 Passed IN Senate August 30, 2021 Passed IN Assembly September 01, 2021 Amended IN Senate August 24, 2021 Amended IN Assembly April 08, 2021 Amended IN Assembly March 16, 2021 CALIFORNIA LEGISLATURE 20212022 REGULAR SESSION Assembly Bill No. 1344Introduced by Assembly Member Arambula(Coauthor: Senator Skinner)February 19, 2021 An act to amend Section 121349 of the Health and Safety Code, relating to public health. LEGISLATIVE COUNSEL'S DIGESTAB 1344, Arambula. State Department of Public Health: needle and syringe exchange services.Existing law authorizes the State Department of Public Health to authorize certain entities to apply to the department to provide hypodermic needle and syringe exchange services in any location where the department determines that the conditions exist for the rapid spread of human immunodeficiency virus (HIV), viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes, and requires the department to provide for a period of public comment during that application process, as specified. Existing law prescribes the standards that apply to an entity that has been authorized to provide these services.Existing law, the California Environmental Quality Act, requires a lead agency, as defined, to prepare, or cause to be prepared, and certify the completion of, an environmental impact report on a project that it proposes to carry out or approve that may have a significant effect on the environment, or to adopt a negative declaration if it finds that the project will not have that effect.This bill would expressly exempt the above-described needle and syringe exchange services application submissions, authorizations, and operations from review under the California Environmental Quality Act. The bill would declare that this provision is intended to be declaratory of existing law. The bill would state that the provisions relating to needle exchange programs are severable.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 121349 of the Health and Safety Code is amended to read:121349. (a) The Legislature finds and declares that scientific data from needle exchange programs in the United States and in Europe have shown that the exchange of used hypodermic needles and syringes for clean hypodermic needles and syringes does not increase drug use in the population, can serve as an important bridge to treatment and recovery from drug abuse, and can curtail the spread of human immunodeficiency virus (HIV) infection among the intravenous drug user population.(b) In order to reduce the spread of HIV infection and bloodborne hepatitis among the intravenous drug user population within California, the Legislature hereby authorizes a clean needle and syringe exchange project pursuant to this chapter in any city, county, or city and county upon the action of a county board of supervisors and the local health officer or health commission of that county, or upon the action of the city council, the mayor, and the local health officer of a city with a health department, or upon the action of the city council and the mayor of a city without a health department.(c) In order to reduce the spread of HIV infection, viral hepatitis, and other potentially deadly bloodborne infections, the State Department of Public Health may, notwithstanding any other law, authorize entities that provide services set forth in paragraph (1) of subdivision (d), and that have sufficient staff and capacity to provide the services described in Section 121349.1, as determined by the department, to apply for authorization under this chapter to provide hypodermic needle and syringe exchange services consistent with state standards in any location where the department determines that the conditions exist for the rapid spread of HIV, viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes. Authorization shall be made after consultation with the local health officer and local law enforcement leadership, and after a period of public comment, as described in subdivision (e). In making the determination, the department shall balance the concerns of law enforcement with the public health benefits. The authorization shall not be for more than two years. Before the end of the two-year period, the department may reauthorize the program in consultation with the local health officer and local law enforcement leadership.(d) In order for an entity to be authorized to conduct a project pursuant to this chapter, its application to the department shall demonstrate that the entity complies with all of the following minimum standards:(1) The entity provides, directly or through referral, all of the following services:(A) Drug abuse treatment services.(B) HIV or hepatitis screening.(C) Hepatitis A and hepatitis B vaccination.(D) Screening for sexually transmitted infections.(E) Housing services for the homeless, for victims of domestic violence, or other similar housing services.(F) Services related to provision of education and materials for the reduction of sexual risk behaviors, including, but not limited to, the distribution of condoms.(2) The entity has the capacity to commence needle and syringe exchange services within three months of authorization.(3) The entity has adequate funding to do all of the following at reasonably projected program participation levels:(A) Provide needles and syringe exchange services for all of its participants.(B) Provide HIV and viral hepatitis prevention education services for all of its participants.(C) Provide for the safe recovery and disposal of used syringes and sharps waste from all of its participants.(4) The entity has the capacity, and an established plan, to collect evaluative data in order to assess program impact, including, but not limited to, all of the following:(A) The total number of persons served.(B) The total number of needles and syringes distributed, recovered, and disposed of.(C) The total numbers and types of referrals to drug treatment and other services.(e) If the application is provisionally deemed appropriate by the department, the department shall, at least 45 days prior to approval of the application, provide for a period of public comment as follows:(1) Post on the departments internet website the name of the applicant, the nature of the services, and the location where the applying entity will provide the services.(2) Send a written and an email notice to the local health officer of the affected jurisdiction.(3) Send a written and an email notice to the chief of police, the sheriff, or both, as appropriate, of the jurisdictions in which the program will operate.(f) The department shall establish and maintain on its internet website the address and contact information of programs providing hypodermic needle and syringe exchange services pursuant to this chapter.(g) The authorization provided under this section is only for a clean needle and syringe exchange project as described in Section 121349.1.(h) (1) Needle and syringe exchange services application submissions, authorizations, and operations performed pursuant to this chapter shall be exempt from review under the California Environmental Quality Act, Division 13 (commencing with Section 21000) of the Public Resources Code.(2) This subdivision is intended to be declaratory of existing law.(i) If the department, in its discretion, determines that a state authorized syringe exchange program continues to meet all standards set forth in subdivision (d) and that a public health need exists, it may administratively approve amendments to a programs operations including, but not limited to, modifications to the time, location, and type of services provided, including the designation as a fixed site or a mobile site. The amendment approval is not subject to the noticing requirements of subdivision (e).(j) The department shall have 30 business days to review and respond to the applicants request for amendment of the authorization. If the department does not respond in writing within 30 business days, the request shall be deemed denied.(k) The provisions of this section are severable. If any provision of this section or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
22
3- Assembly Bill No. 1344 CHAPTER 480 An act to amend Section 121349 of the Health and Safety Code, relating to public health. [ Approved by Governor October 04, 2021. Filed with Secretary of State October 04, 2021. ] LEGISLATIVE COUNSEL'S DIGESTAB 1344, Arambula. State Department of Public Health: needle and syringe exchange services.Existing law authorizes the State Department of Public Health to authorize certain entities to apply to the department to provide hypodermic needle and syringe exchange services in any location where the department determines that the conditions exist for the rapid spread of human immunodeficiency virus (HIV), viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes, and requires the department to provide for a period of public comment during that application process, as specified. Existing law prescribes the standards that apply to an entity that has been authorized to provide these services.Existing law, the California Environmental Quality Act, requires a lead agency, as defined, to prepare, or cause to be prepared, and certify the completion of, an environmental impact report on a project that it proposes to carry out or approve that may have a significant effect on the environment, or to adopt a negative declaration if it finds that the project will not have that effect.This bill would expressly exempt the above-described needle and syringe exchange services application submissions, authorizations, and operations from review under the California Environmental Quality Act. The bill would declare that this provision is intended to be declaratory of existing law. The bill would state that the provisions relating to needle exchange programs are severable.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO
3+ Enrolled September 03, 2021 Passed IN Senate August 30, 2021 Passed IN Assembly September 01, 2021 Amended IN Senate August 24, 2021 Amended IN Assembly April 08, 2021 Amended IN Assembly March 16, 2021 CALIFORNIA LEGISLATURE 20212022 REGULAR SESSION Assembly Bill No. 1344Introduced by Assembly Member Arambula(Coauthor: Senator Skinner)February 19, 2021 An act to amend Section 121349 of the Health and Safety Code, relating to public health. LEGISLATIVE COUNSEL'S DIGESTAB 1344, Arambula. State Department of Public Health: needle and syringe exchange services.Existing law authorizes the State Department of Public Health to authorize certain entities to apply to the department to provide hypodermic needle and syringe exchange services in any location where the department determines that the conditions exist for the rapid spread of human immunodeficiency virus (HIV), viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes, and requires the department to provide for a period of public comment during that application process, as specified. Existing law prescribes the standards that apply to an entity that has been authorized to provide these services.Existing law, the California Environmental Quality Act, requires a lead agency, as defined, to prepare, or cause to be prepared, and certify the completion of, an environmental impact report on a project that it proposes to carry out or approve that may have a significant effect on the environment, or to adopt a negative declaration if it finds that the project will not have that effect.This bill would expressly exempt the above-described needle and syringe exchange services application submissions, authorizations, and operations from review under the California Environmental Quality Act. The bill would declare that this provision is intended to be declaratory of existing law. The bill would state that the provisions relating to needle exchange programs are severable.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO
44
5- Assembly Bill No. 1344 CHAPTER 480
5+ Enrolled September 03, 2021 Passed IN Senate August 30, 2021 Passed IN Assembly September 01, 2021 Amended IN Senate August 24, 2021 Amended IN Assembly April 08, 2021 Amended IN Assembly March 16, 2021
66
7- Assembly Bill No. 1344
7+Enrolled September 03, 2021
8+Passed IN Senate August 30, 2021
9+Passed IN Assembly September 01, 2021
10+Amended IN Senate August 24, 2021
11+Amended IN Assembly April 08, 2021
12+Amended IN Assembly March 16, 2021
813
9- CHAPTER 480
14+ CALIFORNIA LEGISLATURE 20212022 REGULAR SESSION
15+
16+ Assembly Bill
17+
18+No. 1344
19+
20+Introduced by Assembly Member Arambula(Coauthor: Senator Skinner)February 19, 2021
21+
22+Introduced by Assembly Member Arambula(Coauthor: Senator Skinner)
23+February 19, 2021
1024
1125 An act to amend Section 121349 of the Health and Safety Code, relating to public health.
12-
13- [ Approved by Governor October 04, 2021. Filed with Secretary of State October 04, 2021. ]
1426
1527 LEGISLATIVE COUNSEL'S DIGEST
1628
1729 ## LEGISLATIVE COUNSEL'S DIGEST
1830
1931 AB 1344, Arambula. State Department of Public Health: needle and syringe exchange services.
2032
2133 Existing law authorizes the State Department of Public Health to authorize certain entities to apply to the department to provide hypodermic needle and syringe exchange services in any location where the department determines that the conditions exist for the rapid spread of human immunodeficiency virus (HIV), viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes, and requires the department to provide for a period of public comment during that application process, as specified. Existing law prescribes the standards that apply to an entity that has been authorized to provide these services.Existing law, the California Environmental Quality Act, requires a lead agency, as defined, to prepare, or cause to be prepared, and certify the completion of, an environmental impact report on a project that it proposes to carry out or approve that may have a significant effect on the environment, or to adopt a negative declaration if it finds that the project will not have that effect.This bill would expressly exempt the above-described needle and syringe exchange services application submissions, authorizations, and operations from review under the California Environmental Quality Act. The bill would declare that this provision is intended to be declaratory of existing law. The bill would state that the provisions relating to needle exchange programs are severable.
2234
2335 Existing law authorizes the State Department of Public Health to authorize certain entities to apply to the department to provide hypodermic needle and syringe exchange services in any location where the department determines that the conditions exist for the rapid spread of human immunodeficiency virus (HIV), viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes, and requires the department to provide for a period of public comment during that application process, as specified. Existing law prescribes the standards that apply to an entity that has been authorized to provide these services.
2436
2537 Existing law, the California Environmental Quality Act, requires a lead agency, as defined, to prepare, or cause to be prepared, and certify the completion of, an environmental impact report on a project that it proposes to carry out or approve that may have a significant effect on the environment, or to adopt a negative declaration if it finds that the project will not have that effect.
2638
2739 This bill would expressly exempt the above-described needle and syringe exchange services application submissions, authorizations, and operations from review under the California Environmental Quality Act. The bill would declare that this provision is intended to be declaratory of existing law. The bill would state that the provisions relating to needle exchange programs are severable.
2840
2941 ## Digest Key
3042
3143 ## Bill Text
3244
3345 The people of the State of California do enact as follows:SECTION 1. Section 121349 of the Health and Safety Code is amended to read:121349. (a) The Legislature finds and declares that scientific data from needle exchange programs in the United States and in Europe have shown that the exchange of used hypodermic needles and syringes for clean hypodermic needles and syringes does not increase drug use in the population, can serve as an important bridge to treatment and recovery from drug abuse, and can curtail the spread of human immunodeficiency virus (HIV) infection among the intravenous drug user population.(b) In order to reduce the spread of HIV infection and bloodborne hepatitis among the intravenous drug user population within California, the Legislature hereby authorizes a clean needle and syringe exchange project pursuant to this chapter in any city, county, or city and county upon the action of a county board of supervisors and the local health officer or health commission of that county, or upon the action of the city council, the mayor, and the local health officer of a city with a health department, or upon the action of the city council and the mayor of a city without a health department.(c) In order to reduce the spread of HIV infection, viral hepatitis, and other potentially deadly bloodborne infections, the State Department of Public Health may, notwithstanding any other law, authorize entities that provide services set forth in paragraph (1) of subdivision (d), and that have sufficient staff and capacity to provide the services described in Section 121349.1, as determined by the department, to apply for authorization under this chapter to provide hypodermic needle and syringe exchange services consistent with state standards in any location where the department determines that the conditions exist for the rapid spread of HIV, viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes. Authorization shall be made after consultation with the local health officer and local law enforcement leadership, and after a period of public comment, as described in subdivision (e). In making the determination, the department shall balance the concerns of law enforcement with the public health benefits. The authorization shall not be for more than two years. Before the end of the two-year period, the department may reauthorize the program in consultation with the local health officer and local law enforcement leadership.(d) In order for an entity to be authorized to conduct a project pursuant to this chapter, its application to the department shall demonstrate that the entity complies with all of the following minimum standards:(1) The entity provides, directly or through referral, all of the following services:(A) Drug abuse treatment services.(B) HIV or hepatitis screening.(C) Hepatitis A and hepatitis B vaccination.(D) Screening for sexually transmitted infections.(E) Housing services for the homeless, for victims of domestic violence, or other similar housing services.(F) Services related to provision of education and materials for the reduction of sexual risk behaviors, including, but not limited to, the distribution of condoms.(2) The entity has the capacity to commence needle and syringe exchange services within three months of authorization.(3) The entity has adequate funding to do all of the following at reasonably projected program participation levels:(A) Provide needles and syringe exchange services for all of its participants.(B) Provide HIV and viral hepatitis prevention education services for all of its participants.(C) Provide for the safe recovery and disposal of used syringes and sharps waste from all of its participants.(4) The entity has the capacity, and an established plan, to collect evaluative data in order to assess program impact, including, but not limited to, all of the following:(A) The total number of persons served.(B) The total number of needles and syringes distributed, recovered, and disposed of.(C) The total numbers and types of referrals to drug treatment and other services.(e) If the application is provisionally deemed appropriate by the department, the department shall, at least 45 days prior to approval of the application, provide for a period of public comment as follows:(1) Post on the departments internet website the name of the applicant, the nature of the services, and the location where the applying entity will provide the services.(2) Send a written and an email notice to the local health officer of the affected jurisdiction.(3) Send a written and an email notice to the chief of police, the sheriff, or both, as appropriate, of the jurisdictions in which the program will operate.(f) The department shall establish and maintain on its internet website the address and contact information of programs providing hypodermic needle and syringe exchange services pursuant to this chapter.(g) The authorization provided under this section is only for a clean needle and syringe exchange project as described in Section 121349.1.(h) (1) Needle and syringe exchange services application submissions, authorizations, and operations performed pursuant to this chapter shall be exempt from review under the California Environmental Quality Act, Division 13 (commencing with Section 21000) of the Public Resources Code.(2) This subdivision is intended to be declaratory of existing law.(i) If the department, in its discretion, determines that a state authorized syringe exchange program continues to meet all standards set forth in subdivision (d) and that a public health need exists, it may administratively approve amendments to a programs operations including, but not limited to, modifications to the time, location, and type of services provided, including the designation as a fixed site or a mobile site. The amendment approval is not subject to the noticing requirements of subdivision (e).(j) The department shall have 30 business days to review and respond to the applicants request for amendment of the authorization. If the department does not respond in writing within 30 business days, the request shall be deemed denied.(k) The provisions of this section are severable. If any provision of this section or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
3446
3547 The people of the State of California do enact as follows:
3648
3749 ## The people of the State of California do enact as follows:
3850
3951 SECTION 1. Section 121349 of the Health and Safety Code is amended to read:121349. (a) The Legislature finds and declares that scientific data from needle exchange programs in the United States and in Europe have shown that the exchange of used hypodermic needles and syringes for clean hypodermic needles and syringes does not increase drug use in the population, can serve as an important bridge to treatment and recovery from drug abuse, and can curtail the spread of human immunodeficiency virus (HIV) infection among the intravenous drug user population.(b) In order to reduce the spread of HIV infection and bloodborne hepatitis among the intravenous drug user population within California, the Legislature hereby authorizes a clean needle and syringe exchange project pursuant to this chapter in any city, county, or city and county upon the action of a county board of supervisors and the local health officer or health commission of that county, or upon the action of the city council, the mayor, and the local health officer of a city with a health department, or upon the action of the city council and the mayor of a city without a health department.(c) In order to reduce the spread of HIV infection, viral hepatitis, and other potentially deadly bloodborne infections, the State Department of Public Health may, notwithstanding any other law, authorize entities that provide services set forth in paragraph (1) of subdivision (d), and that have sufficient staff and capacity to provide the services described in Section 121349.1, as determined by the department, to apply for authorization under this chapter to provide hypodermic needle and syringe exchange services consistent with state standards in any location where the department determines that the conditions exist for the rapid spread of HIV, viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes. Authorization shall be made after consultation with the local health officer and local law enforcement leadership, and after a period of public comment, as described in subdivision (e). In making the determination, the department shall balance the concerns of law enforcement with the public health benefits. The authorization shall not be for more than two years. Before the end of the two-year period, the department may reauthorize the program in consultation with the local health officer and local law enforcement leadership.(d) In order for an entity to be authorized to conduct a project pursuant to this chapter, its application to the department shall demonstrate that the entity complies with all of the following minimum standards:(1) The entity provides, directly or through referral, all of the following services:(A) Drug abuse treatment services.(B) HIV or hepatitis screening.(C) Hepatitis A and hepatitis B vaccination.(D) Screening for sexually transmitted infections.(E) Housing services for the homeless, for victims of domestic violence, or other similar housing services.(F) Services related to provision of education and materials for the reduction of sexual risk behaviors, including, but not limited to, the distribution of condoms.(2) The entity has the capacity to commence needle and syringe exchange services within three months of authorization.(3) The entity has adequate funding to do all of the following at reasonably projected program participation levels:(A) Provide needles and syringe exchange services for all of its participants.(B) Provide HIV and viral hepatitis prevention education services for all of its participants.(C) Provide for the safe recovery and disposal of used syringes and sharps waste from all of its participants.(4) The entity has the capacity, and an established plan, to collect evaluative data in order to assess program impact, including, but not limited to, all of the following:(A) The total number of persons served.(B) The total number of needles and syringes distributed, recovered, and disposed of.(C) The total numbers and types of referrals to drug treatment and other services.(e) If the application is provisionally deemed appropriate by the department, the department shall, at least 45 days prior to approval of the application, provide for a period of public comment as follows:(1) Post on the departments internet website the name of the applicant, the nature of the services, and the location where the applying entity will provide the services.(2) Send a written and an email notice to the local health officer of the affected jurisdiction.(3) Send a written and an email notice to the chief of police, the sheriff, or both, as appropriate, of the jurisdictions in which the program will operate.(f) The department shall establish and maintain on its internet website the address and contact information of programs providing hypodermic needle and syringe exchange services pursuant to this chapter.(g) The authorization provided under this section is only for a clean needle and syringe exchange project as described in Section 121349.1.(h) (1) Needle and syringe exchange services application submissions, authorizations, and operations performed pursuant to this chapter shall be exempt from review under the California Environmental Quality Act, Division 13 (commencing with Section 21000) of the Public Resources Code.(2) This subdivision is intended to be declaratory of existing law.(i) If the department, in its discretion, determines that a state authorized syringe exchange program continues to meet all standards set forth in subdivision (d) and that a public health need exists, it may administratively approve amendments to a programs operations including, but not limited to, modifications to the time, location, and type of services provided, including the designation as a fixed site or a mobile site. The amendment approval is not subject to the noticing requirements of subdivision (e).(j) The department shall have 30 business days to review and respond to the applicants request for amendment of the authorization. If the department does not respond in writing within 30 business days, the request shall be deemed denied.(k) The provisions of this section are severable. If any provision of this section or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
4052
4153 SECTION 1. Section 121349 of the Health and Safety Code is amended to read:
4254
4355 ### SECTION 1.
4456
4557 121349. (a) The Legislature finds and declares that scientific data from needle exchange programs in the United States and in Europe have shown that the exchange of used hypodermic needles and syringes for clean hypodermic needles and syringes does not increase drug use in the population, can serve as an important bridge to treatment and recovery from drug abuse, and can curtail the spread of human immunodeficiency virus (HIV) infection among the intravenous drug user population.(b) In order to reduce the spread of HIV infection and bloodborne hepatitis among the intravenous drug user population within California, the Legislature hereby authorizes a clean needle and syringe exchange project pursuant to this chapter in any city, county, or city and county upon the action of a county board of supervisors and the local health officer or health commission of that county, or upon the action of the city council, the mayor, and the local health officer of a city with a health department, or upon the action of the city council and the mayor of a city without a health department.(c) In order to reduce the spread of HIV infection, viral hepatitis, and other potentially deadly bloodborne infections, the State Department of Public Health may, notwithstanding any other law, authorize entities that provide services set forth in paragraph (1) of subdivision (d), and that have sufficient staff and capacity to provide the services described in Section 121349.1, as determined by the department, to apply for authorization under this chapter to provide hypodermic needle and syringe exchange services consistent with state standards in any location where the department determines that the conditions exist for the rapid spread of HIV, viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes. Authorization shall be made after consultation with the local health officer and local law enforcement leadership, and after a period of public comment, as described in subdivision (e). In making the determination, the department shall balance the concerns of law enforcement with the public health benefits. The authorization shall not be for more than two years. Before the end of the two-year period, the department may reauthorize the program in consultation with the local health officer and local law enforcement leadership.(d) In order for an entity to be authorized to conduct a project pursuant to this chapter, its application to the department shall demonstrate that the entity complies with all of the following minimum standards:(1) The entity provides, directly or through referral, all of the following services:(A) Drug abuse treatment services.(B) HIV or hepatitis screening.(C) Hepatitis A and hepatitis B vaccination.(D) Screening for sexually transmitted infections.(E) Housing services for the homeless, for victims of domestic violence, or other similar housing services.(F) Services related to provision of education and materials for the reduction of sexual risk behaviors, including, but not limited to, the distribution of condoms.(2) The entity has the capacity to commence needle and syringe exchange services within three months of authorization.(3) The entity has adequate funding to do all of the following at reasonably projected program participation levels:(A) Provide needles and syringe exchange services for all of its participants.(B) Provide HIV and viral hepatitis prevention education services for all of its participants.(C) Provide for the safe recovery and disposal of used syringes and sharps waste from all of its participants.(4) The entity has the capacity, and an established plan, to collect evaluative data in order to assess program impact, including, but not limited to, all of the following:(A) The total number of persons served.(B) The total number of needles and syringes distributed, recovered, and disposed of.(C) The total numbers and types of referrals to drug treatment and other services.(e) If the application is provisionally deemed appropriate by the department, the department shall, at least 45 days prior to approval of the application, provide for a period of public comment as follows:(1) Post on the departments internet website the name of the applicant, the nature of the services, and the location where the applying entity will provide the services.(2) Send a written and an email notice to the local health officer of the affected jurisdiction.(3) Send a written and an email notice to the chief of police, the sheriff, or both, as appropriate, of the jurisdictions in which the program will operate.(f) The department shall establish and maintain on its internet website the address and contact information of programs providing hypodermic needle and syringe exchange services pursuant to this chapter.(g) The authorization provided under this section is only for a clean needle and syringe exchange project as described in Section 121349.1.(h) (1) Needle and syringe exchange services application submissions, authorizations, and operations performed pursuant to this chapter shall be exempt from review under the California Environmental Quality Act, Division 13 (commencing with Section 21000) of the Public Resources Code.(2) This subdivision is intended to be declaratory of existing law.(i) If the department, in its discretion, determines that a state authorized syringe exchange program continues to meet all standards set forth in subdivision (d) and that a public health need exists, it may administratively approve amendments to a programs operations including, but not limited to, modifications to the time, location, and type of services provided, including the designation as a fixed site or a mobile site. The amendment approval is not subject to the noticing requirements of subdivision (e).(j) The department shall have 30 business days to review and respond to the applicants request for amendment of the authorization. If the department does not respond in writing within 30 business days, the request shall be deemed denied.(k) The provisions of this section are severable. If any provision of this section or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
4658
4759 121349. (a) The Legislature finds and declares that scientific data from needle exchange programs in the United States and in Europe have shown that the exchange of used hypodermic needles and syringes for clean hypodermic needles and syringes does not increase drug use in the population, can serve as an important bridge to treatment and recovery from drug abuse, and can curtail the spread of human immunodeficiency virus (HIV) infection among the intravenous drug user population.(b) In order to reduce the spread of HIV infection and bloodborne hepatitis among the intravenous drug user population within California, the Legislature hereby authorizes a clean needle and syringe exchange project pursuant to this chapter in any city, county, or city and county upon the action of a county board of supervisors and the local health officer or health commission of that county, or upon the action of the city council, the mayor, and the local health officer of a city with a health department, or upon the action of the city council and the mayor of a city without a health department.(c) In order to reduce the spread of HIV infection, viral hepatitis, and other potentially deadly bloodborne infections, the State Department of Public Health may, notwithstanding any other law, authorize entities that provide services set forth in paragraph (1) of subdivision (d), and that have sufficient staff and capacity to provide the services described in Section 121349.1, as determined by the department, to apply for authorization under this chapter to provide hypodermic needle and syringe exchange services consistent with state standards in any location where the department determines that the conditions exist for the rapid spread of HIV, viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes. Authorization shall be made after consultation with the local health officer and local law enforcement leadership, and after a period of public comment, as described in subdivision (e). In making the determination, the department shall balance the concerns of law enforcement with the public health benefits. The authorization shall not be for more than two years. Before the end of the two-year period, the department may reauthorize the program in consultation with the local health officer and local law enforcement leadership.(d) In order for an entity to be authorized to conduct a project pursuant to this chapter, its application to the department shall demonstrate that the entity complies with all of the following minimum standards:(1) The entity provides, directly or through referral, all of the following services:(A) Drug abuse treatment services.(B) HIV or hepatitis screening.(C) Hepatitis A and hepatitis B vaccination.(D) Screening for sexually transmitted infections.(E) Housing services for the homeless, for victims of domestic violence, or other similar housing services.(F) Services related to provision of education and materials for the reduction of sexual risk behaviors, including, but not limited to, the distribution of condoms.(2) The entity has the capacity to commence needle and syringe exchange services within three months of authorization.(3) The entity has adequate funding to do all of the following at reasonably projected program participation levels:(A) Provide needles and syringe exchange services for all of its participants.(B) Provide HIV and viral hepatitis prevention education services for all of its participants.(C) Provide for the safe recovery and disposal of used syringes and sharps waste from all of its participants.(4) The entity has the capacity, and an established plan, to collect evaluative data in order to assess program impact, including, but not limited to, all of the following:(A) The total number of persons served.(B) The total number of needles and syringes distributed, recovered, and disposed of.(C) The total numbers and types of referrals to drug treatment and other services.(e) If the application is provisionally deemed appropriate by the department, the department shall, at least 45 days prior to approval of the application, provide for a period of public comment as follows:(1) Post on the departments internet website the name of the applicant, the nature of the services, and the location where the applying entity will provide the services.(2) Send a written and an email notice to the local health officer of the affected jurisdiction.(3) Send a written and an email notice to the chief of police, the sheriff, or both, as appropriate, of the jurisdictions in which the program will operate.(f) The department shall establish and maintain on its internet website the address and contact information of programs providing hypodermic needle and syringe exchange services pursuant to this chapter.(g) The authorization provided under this section is only for a clean needle and syringe exchange project as described in Section 121349.1.(h) (1) Needle and syringe exchange services application submissions, authorizations, and operations performed pursuant to this chapter shall be exempt from review under the California Environmental Quality Act, Division 13 (commencing with Section 21000) of the Public Resources Code.(2) This subdivision is intended to be declaratory of existing law.(i) If the department, in its discretion, determines that a state authorized syringe exchange program continues to meet all standards set forth in subdivision (d) and that a public health need exists, it may administratively approve amendments to a programs operations including, but not limited to, modifications to the time, location, and type of services provided, including the designation as a fixed site or a mobile site. The amendment approval is not subject to the noticing requirements of subdivision (e).(j) The department shall have 30 business days to review and respond to the applicants request for amendment of the authorization. If the department does not respond in writing within 30 business days, the request shall be deemed denied.(k) The provisions of this section are severable. If any provision of this section or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
4860
4961 121349. (a) The Legislature finds and declares that scientific data from needle exchange programs in the United States and in Europe have shown that the exchange of used hypodermic needles and syringes for clean hypodermic needles and syringes does not increase drug use in the population, can serve as an important bridge to treatment and recovery from drug abuse, and can curtail the spread of human immunodeficiency virus (HIV) infection among the intravenous drug user population.(b) In order to reduce the spread of HIV infection and bloodborne hepatitis among the intravenous drug user population within California, the Legislature hereby authorizes a clean needle and syringe exchange project pursuant to this chapter in any city, county, or city and county upon the action of a county board of supervisors and the local health officer or health commission of that county, or upon the action of the city council, the mayor, and the local health officer of a city with a health department, or upon the action of the city council and the mayor of a city without a health department.(c) In order to reduce the spread of HIV infection, viral hepatitis, and other potentially deadly bloodborne infections, the State Department of Public Health may, notwithstanding any other law, authorize entities that provide services set forth in paragraph (1) of subdivision (d), and that have sufficient staff and capacity to provide the services described in Section 121349.1, as determined by the department, to apply for authorization under this chapter to provide hypodermic needle and syringe exchange services consistent with state standards in any location where the department determines that the conditions exist for the rapid spread of HIV, viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes. Authorization shall be made after consultation with the local health officer and local law enforcement leadership, and after a period of public comment, as described in subdivision (e). In making the determination, the department shall balance the concerns of law enforcement with the public health benefits. The authorization shall not be for more than two years. Before the end of the two-year period, the department may reauthorize the program in consultation with the local health officer and local law enforcement leadership.(d) In order for an entity to be authorized to conduct a project pursuant to this chapter, its application to the department shall demonstrate that the entity complies with all of the following minimum standards:(1) The entity provides, directly or through referral, all of the following services:(A) Drug abuse treatment services.(B) HIV or hepatitis screening.(C) Hepatitis A and hepatitis B vaccination.(D) Screening for sexually transmitted infections.(E) Housing services for the homeless, for victims of domestic violence, or other similar housing services.(F) Services related to provision of education and materials for the reduction of sexual risk behaviors, including, but not limited to, the distribution of condoms.(2) The entity has the capacity to commence needle and syringe exchange services within three months of authorization.(3) The entity has adequate funding to do all of the following at reasonably projected program participation levels:(A) Provide needles and syringe exchange services for all of its participants.(B) Provide HIV and viral hepatitis prevention education services for all of its participants.(C) Provide for the safe recovery and disposal of used syringes and sharps waste from all of its participants.(4) The entity has the capacity, and an established plan, to collect evaluative data in order to assess program impact, including, but not limited to, all of the following:(A) The total number of persons served.(B) The total number of needles and syringes distributed, recovered, and disposed of.(C) The total numbers and types of referrals to drug treatment and other services.(e) If the application is provisionally deemed appropriate by the department, the department shall, at least 45 days prior to approval of the application, provide for a period of public comment as follows:(1) Post on the departments internet website the name of the applicant, the nature of the services, and the location where the applying entity will provide the services.(2) Send a written and an email notice to the local health officer of the affected jurisdiction.(3) Send a written and an email notice to the chief of police, the sheriff, or both, as appropriate, of the jurisdictions in which the program will operate.(f) The department shall establish and maintain on its internet website the address and contact information of programs providing hypodermic needle and syringe exchange services pursuant to this chapter.(g) The authorization provided under this section is only for a clean needle and syringe exchange project as described in Section 121349.1.(h) (1) Needle and syringe exchange services application submissions, authorizations, and operations performed pursuant to this chapter shall be exempt from review under the California Environmental Quality Act, Division 13 (commencing with Section 21000) of the Public Resources Code.(2) This subdivision is intended to be declaratory of existing law.(i) If the department, in its discretion, determines that a state authorized syringe exchange program continues to meet all standards set forth in subdivision (d) and that a public health need exists, it may administratively approve amendments to a programs operations including, but not limited to, modifications to the time, location, and type of services provided, including the designation as a fixed site or a mobile site. The amendment approval is not subject to the noticing requirements of subdivision (e).(j) The department shall have 30 business days to review and respond to the applicants request for amendment of the authorization. If the department does not respond in writing within 30 business days, the request shall be deemed denied.(k) The provisions of this section are severable. If any provision of this section or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
5062
5163
5264
5365 121349. (a) The Legislature finds and declares that scientific data from needle exchange programs in the United States and in Europe have shown that the exchange of used hypodermic needles and syringes for clean hypodermic needles and syringes does not increase drug use in the population, can serve as an important bridge to treatment and recovery from drug abuse, and can curtail the spread of human immunodeficiency virus (HIV) infection among the intravenous drug user population.
5466
5567 (b) In order to reduce the spread of HIV infection and bloodborne hepatitis among the intravenous drug user population within California, the Legislature hereby authorizes a clean needle and syringe exchange project pursuant to this chapter in any city, county, or city and county upon the action of a county board of supervisors and the local health officer or health commission of that county, or upon the action of the city council, the mayor, and the local health officer of a city with a health department, or upon the action of the city council and the mayor of a city without a health department.
5668
5769 (c) In order to reduce the spread of HIV infection, viral hepatitis, and other potentially deadly bloodborne infections, the State Department of Public Health may, notwithstanding any other law, authorize entities that provide services set forth in paragraph (1) of subdivision (d), and that have sufficient staff and capacity to provide the services described in Section 121349.1, as determined by the department, to apply for authorization under this chapter to provide hypodermic needle and syringe exchange services consistent with state standards in any location where the department determines that the conditions exist for the rapid spread of HIV, viral hepatitis, or any other potentially deadly or disabling infections that are spread through the sharing of used hypodermic needles and syringes. Authorization shall be made after consultation with the local health officer and local law enforcement leadership, and after a period of public comment, as described in subdivision (e). In making the determination, the department shall balance the concerns of law enforcement with the public health benefits. The authorization shall not be for more than two years. Before the end of the two-year period, the department may reauthorize the program in consultation with the local health officer and local law enforcement leadership.
5870
5971 (d) In order for an entity to be authorized to conduct a project pursuant to this chapter, its application to the department shall demonstrate that the entity complies with all of the following minimum standards:
6072
6173 (1) The entity provides, directly or through referral, all of the following services:
6274
6375 (A) Drug abuse treatment services.
6476
6577 (B) HIV or hepatitis screening.
6678
6779 (C) Hepatitis A and hepatitis B vaccination.
6880
6981 (D) Screening for sexually transmitted infections.
7082
7183 (E) Housing services for the homeless, for victims of domestic violence, or other similar housing services.
7284
7385 (F) Services related to provision of education and materials for the reduction of sexual risk behaviors, including, but not limited to, the distribution of condoms.
7486
7587 (2) The entity has the capacity to commence needle and syringe exchange services within three months of authorization.
7688
7789 (3) The entity has adequate funding to do all of the following at reasonably projected program participation levels:
7890
7991 (A) Provide needles and syringe exchange services for all of its participants.
8092
8193 (B) Provide HIV and viral hepatitis prevention education services for all of its participants.
8294
8395 (C) Provide for the safe recovery and disposal of used syringes and sharps waste from all of its participants.
8496
8597 (4) The entity has the capacity, and an established plan, to collect evaluative data in order to assess program impact, including, but not limited to, all of the following:
8698
8799 (A) The total number of persons served.
88100
89101 (B) The total number of needles and syringes distributed, recovered, and disposed of.
90102
91103 (C) The total numbers and types of referrals to drug treatment and other services.
92104
93105 (e) If the application is provisionally deemed appropriate by the department, the department shall, at least 45 days prior to approval of the application, provide for a period of public comment as follows:
94106
95107 (1) Post on the departments internet website the name of the applicant, the nature of the services, and the location where the applying entity will provide the services.
96108
97109 (2) Send a written and an email notice to the local health officer of the affected jurisdiction.
98110
99111 (3) Send a written and an email notice to the chief of police, the sheriff, or both, as appropriate, of the jurisdictions in which the program will operate.
100112
101113 (f) The department shall establish and maintain on its internet website the address and contact information of programs providing hypodermic needle and syringe exchange services pursuant to this chapter.
102114
103115 (g) The authorization provided under this section is only for a clean needle and syringe exchange project as described in Section 121349.1.
104116
105117 (h) (1) Needle and syringe exchange services application submissions, authorizations, and operations performed pursuant to this chapter shall be exempt from review under the California Environmental Quality Act, Division 13 (commencing with Section 21000) of the Public Resources Code.
106118
107119 (2) This subdivision is intended to be declaratory of existing law.
108120
109121 (i) If the department, in its discretion, determines that a state authorized syringe exchange program continues to meet all standards set forth in subdivision (d) and that a public health need exists, it may administratively approve amendments to a programs operations including, but not limited to, modifications to the time, location, and type of services provided, including the designation as a fixed site or a mobile site. The amendment approval is not subject to the noticing requirements of subdivision (e).
110122
111123 (j) The department shall have 30 business days to review and respond to the applicants request for amendment of the authorization. If the department does not respond in writing within 30 business days, the request shall be deemed denied.
112124
113125 (k) The provisions of this section are severable. If any provision of this section or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.